Exclusive

Publication

Byline

Location

US Patent Issued to Catalent Pharma Solutions on Sept. 8 for "Decorin compositions and use thereof" (Wisconsin Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,227, issued on Sept. 8, was assigned to Catalent Pharma Solutions LLC (Somerset, N.J.). "Decorin compositions and use thereof" was invented... Read More


US Patent Issued to RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL on Sept. 8 for "Transforming growth factor beta-resistant natural killer cells" (Ohio, Missouri Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,228, issued on Sept. 8, was assigned to RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (Columbus, Ohio). "Transforming growth factor ... Read More


US Patent Issued to Amgen on Sept. 8 for "Engineered NRG-1 variants with improved selectivity toward ErbB4 but not against ErbB3" (California, Washington Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,229, issued on Sept. 8, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Engineered NRG-1 variants with improved selectivity toward Erb... Read More


US Patent Issued to Suzhou Forlong Biotechnology on Sept. 8 for "Development and use of interleukin 15 mutant polypeptide" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,230, issued on Sept. 8, was assigned to Suzhou Forlong Biotechnology Co. Ltd. (Jiangsu, China). "Development and use of interleukin 15 muta... Read More


US Patent Issued to SHANGHAI MINWEI BIOTECHNOLOGY on Sept. 8 for "Fusion protein having triple activity and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,231, issued on Sept. 8, was assigned to SHANGHAI MINWEI BIOTECHNOLOGY Co. LTD (Shanghai). "Fusion protein having triple activity and use th... Read More


US Patent Issued to H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE on Sept. 8 for "Artificial antigen presenting cells for genetic engineering of immune cells" (Florida Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,232, issued on Sept. 8, was assigned to H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. (Tampa, Fla.). "Artificial antigen present... Read More


US Patent Issued to DiaMedica USA on Sept. 8 for "Ulinastatin polypeptides" (Minnesota, Wisconsin Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,233, issued on Sept. 8, was assigned to DiaMedica USA Inc.. "Ulinastatin polypeptides" was invented by Rick Pauls (Minneapolis), Todd Verdo... Read More


US Patent Issued to Voyager Therapeutics on Sept. 8 for "Tau binding compounds" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,234, issued on Sept. 8, was assigned to Voyager Therapeutics Inc. (Lexington, Mass.). "Tau binding compounds" was invented by Vinodhbabu Ku... Read More


US Patent Issued to Zoetis Services on Sept. 8 for "Caninized anti-TGFBeta antibodies" (Colorado, Michigan Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,235, issued on Sept. 8, was assigned to Zoetis Services LLC (Parsippany, N.J.). "Caninized anti-TGFBeta antibodies" was invented by Lisa Ma... Read More


US Patent Issued to VALITOR on Sept. 8 for "Hydrophilic linkers for antibody or DARPin conjugates" (California Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,236, issued on Sept. 8, was assigned to VALITOR INC. (Berkeley, Calif.). "Hydrophilic linkers for antibody or DARPin conjugates" was invent... Read More